• Applied Workflows with EZ Cap Cy5 Firefly Luciferase mRNA

  2026-06-10

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) empowers dual-mode detection—combining real-time fluorescence tracking with sensitive luciferase assays—to optimize mRNA delivery and translation workflows. Its Cap1 structure and 5-moUTP modifications deliver enhanced stability and immune evasion, supporting reproducible, high-yield reporter studies in mammalian systems.

• Isoprinosine: Advanced Strategies for Modulating Viral Egres

  2026-06-09

  Explore how Isoprinosine (inosine pranobex) enables precision immunomodulation and targeted inhibition of herpesvirus egress. This article provides new insights for translational virology, linking mechanism to practical assay design.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Workflow Gu

  2026-06-09

  The PKH26 Red Fluorescent Cell Linker Kit enables stable and membrane-specific labeling for cell tracing and proliferation detection in both in vitro and in vivo settings. It is optimized for researchers tracking cell division and membrane dynamics, but should not be used for intracellular or non-membrane targets. Its precise application ensures high specificity and minimal cytotoxicity in membrane-focused studies.

• T7 RNA Polymerase in Inhaled RNA Immunotherapy: Scientific I

  2026-06-08

  Explore how T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, is transforming inhaled RNA immunotherapy and TME engineering. This article delivers in-depth scientific analysis and unique protocol insights that go beyond standard in vitro transcription applications.

• Lisinopril Dihydrate in Experimental ACE Pathway Dissection

  2026-06-08

  Explore the nuanced role of lisinopril dihydrate as a potent ACE inhibitor in advanced disease modeling. This article uniquely evaluates its selectivity, practical assay implications, and mechanistic depth for hypertension and beyond.

• Dihydroartemisinin: Advanced Molecular Insights for Research

  2026-06-07

  Explore the molecular mechanisms and advanced research applications of dihydroartemisinin, an Artemisia plant extract. This article offers a unique, in-depth analysis of its bioactivity, practical assay considerations, and strategic differentiation from existing resources.

• Rapid hiPSC-to-Oligodendrocyte Differentiation via OLIG2 smR

  2026-06-06

  This study introduces a synthetic modified mRNA (smRNA) strategy for the rapid, transgene-free differentiation of human-induced pluripotent stem cells (hiPSCs) into functional oligodendrocytes. By utilizing an OLIG2S147A smRNA, the approach achieves high-efficiency generation of oligodendrocyte progenitors without viral integration, offering a safer and more reliable protocol for cell therapy research.

• Birinapant (TL32711) in Cancer Research: Protocols & Innovat

  2026-06-05

  Birinapant (TL32711) is revolutionizing apoptosis research through robust IAP antagonism, enabling reproducible and sensitive cancer cell death assays. Discover optimized workflows, troubleshooting strategies, and how recent breakthroughs in biomarker-driven therapy, such as MDM1-mediated p53 regulation, can be practically implemented to overcome resistance in oncology models.

• Omeprazole (A2845): Technical Guidance for Research Workflow

  2026-06-05

  Omeprazole (SKU: A2845) is a potent H+,K+-ATPase inhibitor designed for precise control of gastric acid secretion in preclinical research. It is suitable for mechanistic studies on proton pump inhibition and antiulcer agent evaluation, but should not be used for diagnostic or clinical purposes. Researchers must adhere to handling and solubility specifications to ensure reproducibility.

• LY2886721: Strategic BACE1 Inhibition for Translational Rese

  2026-06-04

  Explore the mechanistic, experimental, and translational landscape of BACE1 inhibition in Alzheimer’s disease models, with a focus on LY2886721. This article bridges foundational insights, validated protocols, and actionable strategic guidance for researchers aiming to optimize amyloid beta reduction while safeguarding synaptic function.

• 3-Methyladenine (3-MA): Decoding Autophagy and Vacuolization

  2026-06-04

  Explore how 3-Methyladenine (3-MA) advances autophagy research and uncovers new frontiers in cytoplasmic vacuolization and cell death. This article provides a mechanistic deep dive, protocol insights, and a unique synthesis of recent landmark findings.

• (S)-Mephenytoin as a Precision CYP2C19 Substrate: Assay Desi

  2026-06-03

  (S)-Mephenytoin delivers exceptional specificity as a CYP2C19 substrate for in vitro pharmacokinetic studies. This article reveals deep mechanistic insights and practical assay guidance, uniquely integrating new organoid modeling breakthroughs with critical interpretive strategies.

• Protease Inhibitor Cocktail EDTA-Free: Optimizing Protein In

  2026-06-03

  Explore how the Protease Inhibitor Cocktail EDTA-Free (100X in DMSO) empowers high-fidelity protein workflows, from delicate phosphorylation analysis to advanced stromal cell research. This article offers novel scientific insights and protocol guidance for exceptional protein preservation.

• Entecavir-Associated Thrombocytopenia: Clinical Insights fro

  2026-06-02

  This article analyzes a recent case report documenting severe thrombocytopenia associated with Entecavir treatment in a chronic hepatitis B patient. The findings emphasize the rarity but clinical significance of this adverse event and highlight the importance of regular platelet monitoring and alternative antiviral strategies.

• Remdesivir (GS-5734): Mechanistic Insights for Translational

  2026-06-02

  Explore how Remdesivir (GS-5734) advances translational antiviral research. This article bridges detailed mechanistic understanding of RdRp inhibition with evidence-driven strategies for coronavirus, Ebola, and emerging virus studies—going beyond standard product summaries to provide actionable guidance and future outlook for researchers. The piece highlights the structural basis for nucleoside analogue targeting, protocol optimization, and new frontiers in polymerase-directed therapeutics.

411 records 6/28 page Previous Next First page 上5页 678910 下5页 Last page